SOURCE: Novo Nordisk A/S

February 23, 2009 08:35 ET

Transaction in Own Shares

BAGSVÆRD, DENMARK--(Marketwire - February 23, 2009) - Novo Nordisk A/S - Share repurchase programme


On 29 January 2009 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an amount up to DKK 3.0 billion in the period from 29 January 2009 to 5 August 2009.

Since the announcement as of 16 February 2009, the following transactions have been made under the programme:

                  Number of    Average     Transaction
                   shares   purchase price value, DKK
Accumulated, last
announcement        912,500                280,519,900
16 February 2009     60,500         310.72  18,798,560
17 February 2009     75,000         308.28  23,121,000
18 February 2009     75,000         300.94  22,570,125
19 February 2009     75,000         299.40  22,454,925
20 February 2009     75,000         295.13  22,134,750
Accumulated under
the programme     1,273,000                389,599,260


With the transactions stated above, Novo Nordisk owns a total of 26,077,435 treasury shares, corresponding to 4.1% of the share capital. The total amount of shares in the company is 634,000,000 including treasury shares.

Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs more than 27,000 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit novonordisk.com.

Company Announcement no 10 / 2009


This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.



Copyright © Hugin AS 2009. All rights reserved.

Contact Information